DLA class II alleles are associated with risk for canine symmetrical lupoid onychodystrophy [corrected](SLO).
Symmetrical lupoid onychodystrophy (SLO) is an immune-mediated disease in dogs affecting the claws with a suggested autoimmune aethiology. Sequence-based genotyping of the polymorphic exon 2 from DLA-DRB1, -DQA1, and -DQB1 class II loci were performed in a total of 98 SLO Gordon setter cases and 98 healthy controls. A risk haplotype (DRB1*01801/DQA1*00101/DQB1*00802) was present in 53% of cases and 34% of controls and conferred an elevated risk of developing SLO with an odds ratio (OR) of 2.1. When dogs homozygous for the risk haplotype were compared to all dogs not carrying the haplotype the OR was 5.4. However, a stronger protective haplotype (DRB1*02001/DQA1*00401/DQB1*01303, OR = 0.03, 1/OR = 33) was present in 16.8% of controls, but only in a single case (0.5%). The effect of the protective haplotype was clearly stronger than the risk haplotype, since 11.2% of the controls were heterozygous for the risk and protective haplotypes, whereas this combination was absent from cases. When the dogs with the protective haplotype were excluded, an OR of 2.5 was obtained when dogs homozygous for the risk haplotype were compared to those heterozygous for the risk haplotype, suggesting a co-dominant effect of the risk haplotype. In smaller sample sizes of the bearded collie and giant schnauzer breeds we found the same or similar haplotypes, sharing the same DQA1 allele, over-represented among the cases suggesting that the risk is associated primarily with DLA-DQ. We obtained conclusive results that DLA class II is significantly associated with risk of developing SLO in Gordon setters, thus supporting that SLO is an immune-mediated disease. Further studies of SLO in dogs may provide important insight into immune privilege of the nail apparatus and also knowledge about a number of inflammatory disorders of the nail apparatus like lichen planus, psoriasis, alopecia areata and onycholysis.
Wilbe
Maria
M
Department of Animal Breeding and Genetics, Biomedical Centre, Swedish University of Agricultural Sciences SLU, Uppsala, Sweden. Maria.Wilbe@hgen.slu.se
Ziener
Martine Lund
ML
Aronsson
Anita
A
Harlos
Charlotte
C
Sundberg
Katarina
K
Norberg
Elin
E
Andersson
Lisa
L
Lindblad-Toh
Kerstin
K
Hedhammar
Ake
A
Andersson
Göran
G
Lingaas
Frode
F
D000483:Alleles; D000818:Animals; D004283:Dog Diseases / Q000235:genetics*; D004285:Dogs; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D007154:Immune System Diseases / Q000235:genetics / Q000662:veterinary*; D015810:Linkage Disequilibrium
D015395:Histocompatibility Antigens Class I; C039692:histocompatibility antigen DLA
Tissue Antigens. 2007 Apr;69 Suppl 1:269-71
17445217
Tissue Antigens. 2010 Aug;76(2):110-8
20403140
Immunogenetics. 2001 Oct;53(8):669-73
11797101
Nature. 2005 Dec 8;438(7069):803-19
16341006
Genome Res. 2004 Dec;14(12):2388-96
15545498
J Invest Dermatol. 2005 Dec;125(6):1139-48
16354183
Vet Dermatol. 2000 Jun;11(2):133-141
34645001
Immunogenetics. 2009 Aug;61(8):557-64
19636550
Tissue Antigens. 2010 Jun;75(6):712-9
20210920
Genomics. 2005 Jan;85(1):48-59
15607421
Vet Dermatol. 2008 Apr;19(2):88-94
18336425
J Dtsch Dermatol Ges. 2009 Sep;7(9):787-97
19386022
Tissue Antigens. 2006 Dec;68(6):467-76
17176436
J Am Anim Hosp Assoc. 1995 May-Jun;31(3):194-201
7634051
Perspect Biol Med. 1985 Autumn;29(1):115-31
3906552
Hum Genet. 2009 May;125(4):355-73
19247691
PLoS Genet. 2008 Apr 25;4(4):e1000024
18437207
Vet Dermatol. 1999 Mar;10(1):55-59
34644971
Tissue Antigens. 2006 Jul;68(1):82-6
16774545
Tissue Antigens. 2006 Dec;68(6):502-8
17176441
MedGenMed. 2004 Dec 08;6(4):18
15775845
Curr Dir Autoimmun. 2008;10:27-52
18460879
J Am Anim Hosp Assoc. 2003 Mar-Apr;39(2):139-50
12617542
Acta Vet Scand. 2001;42(3):323-9
11887392
Nat Genet. 2010 Mar;42(3):250-4
20101241